This paper focuses on the impact of China’s export expansion on Malaysian monthly trading with to her 12 major trading partners over the liberalization era. Structural break(s) found mostly coincides with the Asia financial crisis and China’s accession into WTO and, regime shifts are evident...

This study assesses the market structure and competitiveness of Malaysian pharmaceutical industry. A panel analysis of 41 pharmaceutical manufacturing firms over 2004-2012 is conducted founded on the modified Structure-Conduct-Performance (SCP) framework. Our study reveals that the Malaysian...

China appears as the biggest trading partner for ASEAN economy but it is inconclusive whether the complementarities between China and regional economies offset China’s competitive threat. We assess if real exchange fluctuations and the demand-supply channels determine the Malaysia-China trade...

This study assesses the market structure and competitiveness of Malaysian pharmaceutical industry. A panel analysis of 41 pharmaceutical manufacturing firms over 2004-2012 is conducted founded on the modified Structure-Conduct-Performance (SCP) framework. Our study reveals that the Malaysian...

China appears as the biggest trading partner for ASEAN economy but it is inconclusive whether the complementarities between China and regional economies offset China’s competitive threat. We assess if real exchange fluctuations and the demand-supply channels determine the Malaysia-China trade...

This paper focuses on the impact of China’s export expansion on Malaysian monthly trading with to her 12 major trading partners over the liberalization era. Structural break(s) found mostly coincides with the Asia financial crisis and China’s accession into WTO and, regime shifts are evident...